Drug Research
Bayer And NextRNA Partner On New Small Molecule Cancer Drugs
Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug....
Drug Research
Strategies To Improve Cell Line Development For Biologics
The capacity of a cell line to create a biologic that is both safe and stable in large numbers may be considerably improved by...
Drug Research
Nuclear Medicine In North America: Market Growth & Trends
The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to develop rapidly over the...
Drug Research
Bayer & NextRNA Partner In $547Million Cancer Therapy Deal
This summer, Bayer officials made sure Fierce understood that the company's desire for deals hasn't been stifled by a group-wide reorganization. Its most recent...
Clinical Trials
New Endometrial Cancer Therapy Phase-II Trial Shows Promise
The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for...
Clinical Trials
Duality Looks Out For Hong Kong IPO To Finance ADC Trials
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an...
IT & Data Management
Siemens Healthineers To Grow PET Imaging Via Novartis Assets
In a recent development taking place in the last week of August 2024, Siemens Healthineers has gone ahead and agreed to pay over 200...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read